Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Mandala

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to actionAlok A Khorana, Michael B Streiff, Dominique Farge, et al.
European Journal of Cancer (Oxford, England : 1990)|June 10, 2023
Adjuvant therapy for stage II melanoma: the need for further studiesRebecca Lee, Mario Mandala, Georgina V Long, et al.
European Journal of Cancer (Oxford, England : 1990)|August 11, 2024
Treating cancer-associated venous thromboembolism: A practical approachEric Van Cutsem, Isabelle Mahé, Enriqueta Felip, et al.
Future Oncology (London, England)|September 4, 2023
COLUMBUS-AD: phase III study of adjuvant encorafenib + binimetinib in resected stage IIB/IIC BRAF V600-mutated melanomaAlexander Cj van Akkooi, Axel Hauschild, Georgina V Long, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality?Gianluigi Ferretti, Emilio Bria, Diana Giannarelli, et al.
The New Zealand Medical Journal|March 27, 2003
Palliative home care and cost savings: encouraging results from ItalySerena Di Cosimo, Giorgio Pistillucci, Gianluigi Ferretti, et al.
Cancers|December 11, 2022
The Analysis of Trends in Survival for Patients with Melanoma Brain Metastases with Introduction of Novel Therapeutic Options before the Era of Combined Immunotherapy-Multicenter Italian-Polish ReportJoanna Placzke, Paweł Teterycz, Pietro Quaglino, et al.
Journal of the American Academy of Dermatology|November 19, 2018
Prognostic impact of regression in patients with primary cutaneous melanoma >1 mm in thicknessSimone Ribero, Francesca Galli, Simona Osella-Abate, et al.
Cancers|October 29, 2020
Multimodal Treatment of Advanced Mucosal Melanoma in the Era of Modern ImmunotherapyPawel Teterycz, Anna M Czarnecka, Alice Indini, et al.
Journal for Immunotherapy of Cancer|February 17, 2021
SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective studyMario Mandala, Paul Lorigan, Matilde De Luca, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to actionAlok A Khorana, Michael B Streiff, Dominique Farge, et al.
European Journal of Cancer (Oxford, England : 1990)|June 10, 2023
Adjuvant therapy for stage II melanoma: the need for further studiesRebecca Lee, Mario Mandala, Georgina V Long, et al.
European Journal of Cancer (Oxford, England : 1990)|August 11, 2024
Treating cancer-associated venous thromboembolism: A practical approachEric Van Cutsem, Isabelle Mahé, Enriqueta Felip, et al.
Future Oncology (London, England)|September 4, 2023
COLUMBUS-AD: phase III study of adjuvant encorafenib + binimetinib in resected stage IIB/IIC BRAF V600-mutated melanomaAlexander Cj van Akkooi, Axel Hauschild, Georgina V Long, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality?Gianluigi Ferretti, Emilio Bria, Diana Giannarelli, et al.
The New Zealand Medical Journal|March 27, 2003
Palliative home care and cost savings: encouraging results from ItalySerena Di Cosimo, Giorgio Pistillucci, Gianluigi Ferretti, et al.
Cancers|December 11, 2022
The Analysis of Trends in Survival for Patients with Melanoma Brain Metastases with Introduction of Novel Therapeutic Options before the Era of Combined Immunotherapy-Multicenter Italian-Polish ReportJoanna Placzke, Paweł Teterycz, Pietro Quaglino, et al.
Journal of the American Academy of Dermatology|November 19, 2018
Prognostic impact of regression in patients with primary cutaneous melanoma >1 mm in thicknessSimone Ribero, Francesca Galli, Simona Osella-Abate, et al.
Cancers|October 29, 2020
Multimodal Treatment of Advanced Mucosal Melanoma in the Era of Modern ImmunotherapyPawel Teterycz, Anna M Czarnecka, Alice Indini, et al.
Journal for Immunotherapy of Cancer|February 17, 2021
SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective studyMario Mandala, Paul Lorigan, Matilde De Luca, et al.
Pageof 7